1. Home
  2. BWXT vs RGEN Comparison

BWXT vs RGEN Comparison

Compare BWXT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWXT
  • RGEN
  • Stock Information
  • Founded
  • BWXT 1867
  • RGEN 1981
  • Country
  • BWXT United States
  • RGEN United States
  • Employees
  • BWXT N/A
  • RGEN N/A
  • Industry
  • BWXT
  • RGEN Medical/Dental Instruments
  • Sector
  • BWXT
  • RGEN Health Care
  • Exchange
  • BWXT Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • BWXT 8.9B
  • RGEN 9.2B
  • IPO Year
  • BWXT N/A
  • RGEN N/A
  • Fundamental
  • Price
  • BWXT $95.71
  • RGEN $147.07
  • Analyst Decision
  • BWXT Buy
  • RGEN Buy
  • Analyst Count
  • BWXT 8
  • RGEN 10
  • Target Price
  • BWXT $102.57
  • RGEN $188.38
  • AVG Volume (30 Days)
  • BWXT 391.5K
  • RGEN 871.2K
  • Earning Date
  • BWXT 10-30-2024
  • RGEN 10-29-2024
  • Dividend Yield
  • BWXT 1.00%
  • RGEN N/A
  • EPS Growth
  • BWXT 19.66
  • RGEN N/A
  • EPS
  • BWXT 2.92
  • RGEN N/A
  • Revenue
  • BWXT $2,600,935,000.00
  • RGEN $602,354,000.00
  • Revenue This Year
  • BWXT $8.08
  • RGEN $0.08
  • Revenue Next Year
  • BWXT $4.71
  • RGEN $12.97
  • P/E Ratio
  • BWXT $32.79
  • RGEN N/A
  • Revenue Growth
  • BWXT 11.69
  • RGEN N/A
  • 52 Week Low
  • BWXT $71.55
  • RGEN $110.45
  • 52 Week High
  • BWXT $107.18
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • BWXT 38.78
  • RGEN 48.18
  • Support Level
  • BWXT $100.60
  • RGEN $139.41
  • Resistance Level
  • BWXT $104.32
  • RGEN $152.92
  • Average True Range (ATR)
  • BWXT 1.88
  • RGEN 5.53
  • MACD
  • BWXT -0.54
  • RGEN -1.29
  • Stochastic Oscillator
  • BWXT 0.12
  • RGEN 43.82

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer & service provider of nuclear components. It operates in two segments. The government Operations segment consists of legacy Nuclear Operations Group & Nuclear Services Group segments with certain research & development activities in the areas of advanced reactors & advanced manufacturing. The commercial Operations segment consists of the legacy Nuclear Power Group segment with certain research and development & commercialization activities in the areas of medical & industrial radioisotopes & radiopharmaceuticals. The majority is from the Government Operations segment. Geographically, it operates in the United States, Canada & United Kingdom, out of which the majority is from the United States.

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

Share on Social Networks: